Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 232

1.

Psychometric properties of the EQ-5D-5L in the general population of South Korea.

Kim TH, Jo MW, Lee SI, Kim SH, Chung SM.

Qual Life Res. 2013 Oct;22(8):2245-53. doi: 10.1007/s11136-012-0331-3. Epub 2012 Dec 6.

PMID:
23224560
2.

Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea.

Kim SH, Kim HJ, Lee SI, Jo MW.

Qual Life Res. 2012 Aug;21(6):1065-73. doi: 10.1007/s11136-011-0018-1. Epub 2011 Sep 23.

PMID:
21947656
3.

Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.

Pattanaphesaj J, Thavorncharoensap M.

Health Qual Life Outcomes. 2015 Feb 6;13:14. doi: 10.1186/s12955-014-0203-3.

4.

Validity of EQ-5D-5L in stroke.

Golicki D, Niewada M, Buczek J, Karlińska A, Kobayashi A, Janssen MF, Pickard AS.

Qual Life Res. 2015 Apr;24(4):845-50. doi: 10.1007/s11136-014-0834-1. Epub 2014 Oct 28.

5.

Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases.

Sakthong P, Sonsa-Ardjit N, Sukarnjanaset P, Munpan W.

Qual Life Res. 2015 Dec;24(12):3015-22. doi: 10.1007/s11136-015-1038-z. Epub 2015 Jun 6.

PMID:
26048348
6.

Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study.

Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, Swinburn P, Busschbach J.

Qual Life Res. 2013 Sep;22(7):1717-27. doi: 10.1007/s11136-012-0322-4. Epub 2012 Nov 25.

7.

Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece.

Yfantopoulos JN, Chantzaras AE.

Eur J Health Econ. 2017 May;18(4):519-531. doi: 10.1007/s10198-016-0807-0. Epub 2016 Jun 4.

PMID:
27262480
8.

Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis.

Yfantopoulos J, Chantzaras A, Kontodimas S.

Arch Dermatol Res. 2017 Jul;309(5):357-370. doi: 10.1007/s00403-017-1743-2. Epub 2017 May 20.

PMID:
28528371
9.

Reliability and validity of the EQ-5D-5L compared to the EQ-5D-3L in patients with osteoarthritis referred for hip and knee replacement.

Conner-Spady BL, Marshall DA, Bohm E, Dunbar MJ, Loucks L, Al Khudairy A, Noseworthy TW.

Qual Life Res. 2015 Jul;24(7):1775-84. doi: 10.1007/s11136-014-0910-6. Epub 2015 Jan 3.

PMID:
25555837
10.

Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases.

Scalone L, Ciampichini R, Fagiuoli S, Gardini I, Fusco F, Gaeta L, Del Prete A, Cesana G, Mantovani LG.

Qual Life Res. 2013 Sep;22(7):1707-16. doi: 10.1007/s11136-012-0318-0. Epub 2012 Nov 29.

PMID:
23192232
11.

EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.

Wong CKH, Lang BHH, Yu HMS, Lam CLK.

Patient. 2017 Aug;10(4):447-454. doi: 10.1007/s40271-017-0220-5.

PMID:
28224296
12.

Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients.

Pickard AS, De Leon MC, Kohlmann T, Cella D, Rosenbloom S.

Med Care. 2007 Mar;45(3):259-63.

PMID:
17304084
13.

Psychometric properties of the EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children.

Khanna R, Jariwala K, Bentley JP.

Qual Life Res. 2013 Dec;22(10):2909-20. doi: 10.1007/s11136-013-0423-8. Epub 2013 Apr 25.

PMID:
23615959
14.

Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?

Feng Y, Devlin N, Herdman M.

Health Qual Life Outcomes. 2015 Oct 21;13:171. doi: 10.1186/s12955-015-0356-8.

15.

Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B.

Jia YX, Cui FQ, Li L, Zhang DL, Zhang GM, Wang FZ, Gong XH, Zheng H, Wu ZH, Miao N, Sun XJ, Zhang L, Lv JJ, Yang F.

Qual Life Res. 2014 Oct;23(8):2355-63. doi: 10.1007/s11136-014-0670-3. Epub 2014 Mar 14.

PMID:
24627090
16.

The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients.

Pan CW, Sun HP, Wang X, Ma Q, Xu Y, Luo N, Wang P.

Qual Life Res. 2015 Jul;24(7):1767-74. doi: 10.1007/s11136-014-0902-6. Epub 2014 Dec 25.

PMID:
25540029
17.

Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.

McCaffrey N, Kaambwa B, Currow DC, Ratcliffe J.

Health Qual Life Outcomes. 2016 Sep 20;14(1):133. doi: 10.1186/s12955-016-0537-0.

18.

Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients.

Golicki D, Niewada M, Karlińska A, Buczek J, Kobayashi A, Janssen MF, Pickard AS.

Qual Life Res. 2015 Jun;24(6):1555-63. doi: 10.1007/s11136-014-0873-7. Epub 2014 Nov 26.

19.

A comparison of the scaling properties of the English, Spanish, French, and Chinese EQ-5D descriptive systems.

Luo N, Li M, Chevalier J, Lloyd A, Herdman M.

Qual Life Res. 2013 Oct;22(8):2237-43. doi: 10.1007/s11136-012-0342-0. Epub 2012 Dec 25.

PMID:
23266797
20.

Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.

García-Gordillo M, del Pozo-Cruz B, Adsuar JC, Sánchez-Martínez FI, Abellán-Perpiñán JM.

Qual Life Res. 2014 May;23(4):1315-26. doi: 10.1007/s11136-013-0569-4. Epub 2013 Nov 22.

PMID:
24258254

Supplemental Content

Support Center